ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Triple antiviral drug combination shows early promise for treating COVID-19 in Phase II trial
May 12, 2020A Phase II clinical trial has shown that a two-week course of interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within seven days of showing COVID-19 symptoms, is safe and effective. -
New triple antiviral drugs combo shows promise against COVID-19: Study
May 11, 2020Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is better at reducing the viral load.
Pharma Sources Insight January 2025
